Neuroone Medical Technologies (NMTC) Current Leases (2023 - 2024)
Neuroone Medical Technologies (NMTC) reported Current Leases of $65768.0 for Q3 2024, down 49.06% year-over-year from $129116.0 in Q4 2023, and down 49.06% sequentially from $129116.0 in Q3 2023.
Neuroone Medical Technologies (NMTC) Current Leases (2023 - 2024) Analysis & Trends
Neuroone Medical Technologies has disclosed Current Leases across 2 years of filings, most recently posting $65768.0 for Q3 2024.
- Quarterly Current Leases fell 49.06% year-over-year to $65768.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $65768.0 (down 49.06% YoY) and the FY2024 annual result came in at $65768.0, down 49.06% from the prior year.
- Current Leases declined to $65768.0 in Q3 2024, from $129116.0 in the prior quarter.
- Across five years, Current Leases topped out at $129116.0 in Q3 2023 and bottomed at $65768.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 24.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 20.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 35.80 Mn |
| 10 | Neuroone Medical Technologies | 26.73 Mn | 23.93 Mn | 990,264.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 65,768.00 |
| Sep 30, 2023 | 129,116.00 |